Labcorp
1,033 hedge funds and large institutions have $21.6B invested in Labcorp in 2022 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 368 increasing their positions, 399 reducing their positions, and 102 closing their positions.
214% more call options, than puts
Call options by funds: $186M | Put options by funds: $59.2M
0.11% more ownership
Funds ownership: 102.48% → 102.59% (+0.11%)
8% less repeat investments, than reductions
Existing positions increased: 368 | Existing positions reduced: 399
3% less funds holding
Funds holding: 1,061 → 1,033 (-28)
18% less first-time investments, than exits
New positions opened: 84 | Existing positions closed: 102
18% less capital invested
Capital invested by funds: $26.3B → $21.6B (-$4.68B)
33% less funds holding in top 10
Funds holding in top 10: 30 → 20 (-10)
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$472M |
| 2 |
BlackRock
New York
|
+$357M |
| 3 |
D.E. Shaw & Co
New York
|
+$125M |
| 4 |
Barclays
London,
United Kingdom
|
+$69.5M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$69.5M |
Top Sellers
| 1 |
MCM
Melvin Capital Management
New York
|
-$329M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$255M |
| 3 |
Lazard Asset Management
New York
|
-$211M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$187M |
| 5 |
Millennium Management
New York
|
-$73.9M |
LH Hedge Fund Activity: Q1 2022 in Review
1,033 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q1 2022, worth a combined $21.6B — down 18% from $26.3B a quarter earlier.
Sellers outnumbered buyers: 102 funds closed out of LH and 84 opened new positions — a net loss of 18 holders — while 399 trimmed existing stakes and 368 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $472M. The largest seller was Melvin Capital Management, cutting an estimated $329M.
- 1,033 institutional investors held Labcorp (LH) as of Q1 2022, down from 1,061 in Q4 2021.
- Funds reported $21.6B of Labcorp stock for Q1 2022, down 18% quarter-over-quarter.
- 84 funds opened new Labcorp positions in Q1 2022 and 102 closed out, a net change of -18 holders.
- The largest Labcorp buyer in Q1 2022 was T. Rowe Price Associates, an estimated $472M added.
- The largest Labcorp seller in Q1 2022 was Melvin Capital Management, an estimated $329M sold.
Based on aggregated 13F filings for Q1 2022.